GSK-F1
| CAS No. | 1402345-92-9 | Cat. No. | BCP29575 |
| Name | GSK-F1 | ||
| Synonyms | 1384097-27-1；rac-GSK-F1; | ||
| Formula | C27H18F5N5O4S | M. Wt | 603.52 |
| Description | GSK-F1 is a potent inhibitor of PI4KA. It has markedly better pharmacokinetic properties in vivo with respects to GSK-A1 . GSK-F1 does not cross the blood-brain barrier. Phosphatidylinositol 4-kinase type IIIα (PI4KA) is a host factor essential for hepatitis C virus replication and hence is a target for drug development. RNAi studies have shown that PI4KA is a mandatory host factor in HCV replication. Down-regulation of PI4KA appears to be reasonably tolerated by cultured cell models and results. | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | PI4K | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.